Harmony Biosciences Holdings HRMY spent $250K on lobbying in Q4 2022 · Health Issues, Taxation

Trade details

Type: Lobbying report
Amount: $250,000
Quarter: Q4 2022
Stock: Harmony Biosciences Holdings HRMY
Client: Harmony Biosciences
Reported: 23/01/19

$350K on lobbying in 2022

What else happened in Harmony Biosciences Holdings around then

Filed or reported within 30 days of the trade day · 22/12/01~23/01/30

Harmony Biosciences's other lobbying reports

Harmony Biosciences
LobbyingHarmony Biosciences Holdings
Lobbying
Harmony Biosciences Holdings
HRMY
$20K
$20K
Reported 07/20
for Q2
Harmony Biosciences
LobbyingHarmony Biosciences Holdings
Lobbying
Harmony Biosciences Holdings
HRMY
$50K
$50K
Reported 07/20
for Q2
Harmony Biosciences
LobbyingHarmony Biosciences Holdings
Lobbying
Harmony Biosciences Holdings
HRMY
$180K
$180K
Reported 07/20
for Q2
Harmony Biosciences
LobbyingHarmony Biosciences Holdings
Lobbying
Harmony Biosciences Holdings
HRMY
$50K
$50K
Reported 07/05
for Q2
Harmony Biosciences
LobbyingHarmony Biosciences Holdings
Lobbying
Harmony Biosciences Holdings
HRMY
$30K
$30K
Reported 05/04
for Q1